Tinambacan, Baby Girl .
HRN: 22-28-53 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/03/2022
AMPICILLIN 250MG (VIAL)
12/03/2022
12/10/2022
IV
60mg
Q12hours
PSNB Sec Non-institutional Delivery; RDS Sec Prematurity
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes